Abstract: The present disclosure provides an O/W emulsion composition, comprising an adenosine phosphate and/or a salt thereof; an acrylic acid-alkyl, methacrylate copolymer; an oil content; and water; and comprising a water-soluble polymer selected from a swelling thickener, an associative thickener, a polysaccharide and a derivative thereof, and a mixture thereof, and/or a pH adjuster which is an organic alkali compound; wherein the composition has a viscosity of equal to or higher than 10,000 mPa·s.

Abstract: The present disclosure provides an O/W emulsion composition, comprising an adenosine phosphate and/or a salt thereof; an acrylic acid-alkyl methacrylate copolymer; an oil content; and water; and comprising a water-soluble polymer selected from a swelling thickener, an associative thickener, a polysaccharide and a derivative thereof and a mixture thereof, and/or a pH adjuster which is an organic alkali compound; wherein the composition has a viscosity of less than 10,000 mPa·s.

Abstract: The present disclosure provides a composition for external use comprising an adenosine phosphate and/or a salt thereof and tranexamic acid and/or a salt thereof, which further comprises a particular chelating agent and/or a pH adjuster that is an organic alkali compound.

Abstract: A major object of the present invention is to provide a skin emulsion composition comprising at least one member selected from the group consisting of polyacrylic acids and salts thereof, an alkyl-modified carboxy polymer, and a compound represented by formula (I) wherein R1, R2, and R3 are the same or different and represent C1-3 alkyl or C1-3 alkyl substituted with at least one hydroxyl group, with the proviso that at least one of R1, R2, and R3 is C1-3 alkyl substituted with at least one hydroxyl group, with the viscosity of the composition being 10,000 mPa·s or more.